FDA DrugsClass II
Levothyroxine Sodium Tablets USP 150 mcg, 1000 Tablets bottle, Rx Only, Manufact...
Published: April 1, 2026Recall ID: D-0403-2026Category: drugsCountry: US
Reason for Recall / Hazard
Subpotent Drug
Product Description & Identification
Levothyroxine Sodium Tablets USP 150 mcg, 1000 Tablets bottle, Rx Only, Manufactured for: Macleods Pharma USA, Inc., Princeton, NJ, Manufactured by: Macleods Pharmaceuticals Ltd., Sarigam, Valsad, Guajarat, INDIA NDC 33342-401-44
Additional Source Details
| Field | Value |
|---|---|
| City | Princeton |
| State | NJ |
| Openfda › Upc › 1 | 0333342393104 |
| Openfda › Upc › 2 | 0333342397102 |
| Openfda › Upc › 3 | 0333342404107 |
| Openfda › Upc › 4 | 0333342393111 |
| Openfda › Upc › 5 | 0333342400109 |
| Openfda › Upc › 6 | 0333342403100 |
| Openfda › Upc › 7 | 0333342393449 |
| Openfda › Upc › 8 | 0333342394101 |
| Openfda › Upc › 9 | 0333342402103 |
| Openfda › Upc › 10 | 0333342396105 |
| Openfda › Upc › 11 | 0333342395108 |
| Openfda › Upc › 12 | 0333342398109 |
| Openfda › Upc › 13 | 0333342399106 |
| Openfda › Unii | 9J765S329G |
| Openfda › Route | ORAL |
| Openfda › Rxcui › 1 | 892246 |
| Openfda › Rxcui › 2 | 892251 |
| Openfda › Rxcui › 3 | 892255 |
| Openfda › Rxcui › 4 | 966220 |
| Openfda › Rxcui › 5 | 966221 |
| Openfda › Rxcui › 6 | 966222 |
| Openfda › Rxcui › 7 | 966224 |
| Openfda › Rxcui › 8 | 966225 |
| Openfda › Rxcui › 9 | 966248 |
| Openfda › Rxcui › 10 | 966249 |
| Openfda › Rxcui › 11 | 966253 |
| Openfda › Rxcui › 12 | 966270 |
| Openfda › Spl id | 3a77ca51-7d8a-4755-aabc-3801cc772a10 |
| Openfda › Brand name | LEVOTHYROXINE SODIUM |
| Openfda › Spl set id | b8c20f76-3ee6-4b29-b77f-ed4ad1baaed9 |
| Openfda › Package ndc › 1 | 33342-393-10 |
| Openfda › Package ndc › 2 | 33342-393-11 |
| Openfda › Package ndc › 3 | 33342-393-44 |
| Openfda › Package ndc › 4 | 33342-394-10 |
| Openfda › Package ndc › 5 | 33342-394-11 |
| Openfda › Package ndc › 6 | 33342-394-44 |
| Openfda › Package ndc › 7 | 33342-395-10 |
| Openfda › Package ndc › 8 | 33342-395-11 |
| Openfda › Package ndc › 9 | 33342-395-44 |
| Openfda › Package ndc › 10 | 33342-396-10 |
| Openfda › Package ndc › 11 | 33342-396-11 |
| Openfda › Package ndc › 12 | 33342-396-44 |
| Openfda › Package ndc › 13 | 33342-397-10 |
| Openfda › Package ndc › 14 | 33342-397-11 |
| Openfda › Package ndc › 15 | 33342-397-44 |
| Openfda › Package ndc › 16 | 33342-398-10 |
| Openfda › Package ndc › 17 | 33342-398-11 |
| Openfda › Package ndc › 18 | 33342-398-44 |
| Openfda › Package ndc › 19 | 33342-399-10 |
| Openfda › Package ndc › 20 | 33342-399-11 |
| Openfda › Package ndc › 21 | 33342-399-44 |
| Openfda › Package ndc › 22 | 33342-400-10 |
| Openfda › Package ndc › 23 | 33342-400-11 |
| Openfda › Package ndc › 24 | 33342-400-44 |
| Openfda › Package ndc › 25 | 33342-401-10 |
| Openfda › Package ndc › 26 | 33342-401-11 |
| Openfda › Package ndc › 27 | 33342-401-44 |
| Openfda › Package ndc › 28 | 33342-402-10 |
| Openfda › Package ndc › 29 | 33342-402-11 |
| Openfda › Package ndc › 30 | 33342-402-44 |
| Openfda › Package ndc › 31 | 33342-403-10 |
| Openfda › Package ndc › 32 | 33342-403-11 |
| Openfda › Package ndc › 33 | 33342-403-44 |
| Openfda › Package ndc › 34 | 33342-404-10 |
| Openfda › Package ndc › 35 | 33342-404-11 |
| Openfda › Package ndc › 36 | 33342-404-44 |
| Openfda › Product ndc › 1 | 33342-393 |
| Openfda › Product ndc › 2 | 33342-394 |
| Openfda › Product ndc › 3 | 33342-395 |
| Openfda › Product ndc › 4 | 33342-396 |
| Openfda › Product ndc › 5 | 33342-397 |
| Openfda › Product ndc › 6 | 33342-398 |
| Openfda › Product ndc › 7 | 33342-399 |
| Openfda › Product ndc › 8 | 33342-400 |
| Openfda › Product ndc › 9 | 33342-401 |
| Openfda › Product ndc › 10 | 33342-402 |
| Openfda › Product ndc › 11 | 33342-403 |
| Openfda › Product ndc › 12 | 33342-404 |
| Openfda › Generic name | LEVOTHYROXINE SODIUM |
| Openfda › Product type | HUMAN PRESCRIPTION DRUG |
| Openfda › Substance name | LEVOTHYROXINE SODIUM |
| Openfda › Manufacturer name | Macleods Pharmaceuticals Limited |
| Openfda › Application number | ANDA211417 |
| Openfda › Is original packager | true |
| Event id | 98510 |
| Address 1 | 103 College Rd E Fl 2 |
| Code info | Lot 16240062A, exp date 3/2026 |
| Postal code | 08540-6611 |
| Report date | 20260401 |
| Product type | Drugs |
| Product quantity | 1315 bottles |
| Reason for recall | Subpotent Drug |
| Voluntary mandated | Voluntary: Firm initiated |
| Recall initiation date | 20260226 |
| Initial firm notification | Letter |
| Center classification date | 20260324 |
Overview
- Recalling FirmMACLEODS PHARMA USA, INC
- StatusOngoing
- Risk LevelClass II
- DistributionNationwide